Chu, G. http://orcid.org/0000-0001-5466-3094
Seelig, J.
Trinks-Roerdink, E. M.
Geersing, G. J.
Rutten, F. H.
de Groot, J. R.
Huisman, M. V.
Hemels, M. E. W.
Article History
First Online: 11 August 2020
Conflict of interest
: G. Chu is supported by a research grant of ZonMW (project numbers 848050006 and 848050007). J. Seelig is supported by a grant from the Dutch Federation of Anticoagulation Clinics (FNT). E.M. Trinks-Roerdink reports no conflicts of interests. G. J. Geersing and F. H. Rutten received unrestricted institutional grants from Bayer, BMS/Pfizer, Boehringer Ingelheim, Daiichi Sankyo. J. R. de Groot received research grants (through institution) from Abbot, Atricure, Bayer, Boston Scientific, Medtronic. Received speaker/consultancy fees from Atricure, Bayer, Daiichi Sankyo, Johnson&Johnson, Medtronic, Novartis, Servier. Ownership: RhythmCARE. M. V. Huisman reports unrestricted grants from and personal fees from ZONMW, Boehringer Ingelheim, Pfizer/BMS, Bayer Health Care, Aspen, Daiichi Sankyo, outside the submitted work. M. E. W. Hemels received consultancy fees from Bayer, BMS/Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Roche and received a research grant from Federation of Dutch Thrombosis Services.